Výsledky vyhledávání

Akademický článek

Autologous stem cell transplantation for aggressive non-Hodgkin's lymphomas

Autor: G. Santini, A. M. Congiu, S. Nati, G. Marino, V. Nardi, M. Spriano, R. Vimercati, A. Rubagotti, C. A. Souza

Publikováno v: Revista Brasileira de Hematologia e Hemoterapia, Vol 24, Iss 2, Pp 77-84 (2002)

Autologous stem cell transplantation (ASCT) has been seen to overcome resistance, allowing an increase in the dose of available drugs and radiotherapy. Initially used after first-line for relapsed or refractory non-Hodgkin's lymphomas (NHL), ASCT has

Externí odkaz: https://doaj.org/article/c2df77d54c7944999373d90bd0c33ec3

Zobrazit plný text záznamu

Recombinant human erythropoietin in the anemia associated with multiple myeloma or non-Hodgkin's lymphoma: dose finding and identification of predictors of response

Autor: R Cimino, M Spriano, U Essers, A Najman, A Grossi, D Bron, D Messinger, A LeMevel, L Enller-Ziegler, Vittorio Silingardi, V Battistel, G Jager, Mario Cazzola, Richard Greil, B Ehmer, A. Van Hoof

Publikováno v: Blood. 86:4446-4453

Previous phase I-II clinical trials have shown that recombinant human erythropoietin (rHuEpo) can ameliorate anemia in a portion of patients with multiple myeloma (MM) and non-Hodgkin's lymphoma (NHL). Therefore, we performed a randomized controlled

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::d1e944774db17b16adfda86d5eed5c8b
https://doi.org/10.1182/blood.v86.12.4446.bloodjournal86124446

Zobrazit plný text záznamu

Fludarabine in combination with cyclophosphamide or with cyclophosphamide plus mitoxantrone for relapsed or refractory low-grade non-Hodgkin's lymphoma

Autor: G, Santini, S, Nati, M, Spriano, A, Gallamini, D, Pierluigi, A M, Congiu, M, Truini, A, Rubagotti, T, Chisesi, R, Vimercati, E, Rossi, M R, Sertoli, D, Mattei, G, Marino, M, Gobbi

Publikováno v: Haematologica. 86(3)

We report the activity of two combinations of fludarabine (FLU), one with cyclophosphamide (FLU/CY) and the second with CY plus mitoxantrone (FLU/CY/MITO). The aim of the study was to evaluate the activity and toxicity of these two schedules in patie

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::ca718d1d0a1301a33e431a107480d738
https://pubmed.ncbi.nlm.nih.gov/11255275

Zobrazit plný text záznamu

Alpha-interferon as induction and maintenance therapy in hairy cell leukemia: a long-term follow-up analysis

Autor: E E, Damasio, M, Clavio, B, Masoudi, A, Isaza, M, Spriano, E, Rossi, S, Casciaro, R, Cerri, M, Risso, S, Nati, M, Siccardi, M, Truini, M, Gobbi

Publikováno v: European journal of haematology. 64(1)

Although in recent years the use of purine analogues has increased the percentage of long-term complete response the effect on overall survival of patients with hairy cell leukemia (HCL) is not yet clear. This study aimed to evaluate the long-term ou

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::35cc682320e525739768754ddddf4f94
https://pubmed.ncbi.nlm.nih.gov/10680705

Zobrazit plný text záznamu

Five day intermittent vs seven day continuous 2-chlorodeoxyadenosine infusion for the treatment of hairy cell leukemia. A study by Italian Group for the Hairy Cell Leukemia

Autor: E E, Damasio, L, Resegotti, B, Masoudi, R, Bruni, R, Cerri, A, Isaza, M, Clavio, M, Risso, E, Rossi, M, Spriano, M, Truini

Publikováno v: Recenti progressi in medicina. 89(2)

The new purine-analogue 2-chlorodeoxyadenosine (2-CdA) has proved to induce an high CR rate and a long lasting disease free survival. In this study we compare the efficacy and toxicity of 2-CdA employed in two different schedules (A and B). Forty-one

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::f338382949ad0a8c7375fd6ca64640f7
https://pubmed.ncbi.nlm.nih.gov/9558908

Zobrazit plný text záznamu

Mobilization/transplantation of peripheral blood progenitor cells for aggressive non-Hodgkin's lymphoma with marrow involvement

Autor: G, Santini, A M, Congiu, S, Nati, D, Pierluigi, M, Spriano, T, Chisesi, E, Rossi, R, Vimercati, M R, Sertoli, O, Figari, M, Gobbi, G, Piaggio, F, Vassallo, F, Benvenuto, M, Soracco, M, Miglino, R, Bruni, J L, Ravetti, M, Truini

Publikováno v: Leukemia. 10

Thirty-five aggressive non-Hodgkin's lymphomas (NHL) with marrow involvement received high-dose cyclophosphamide (7 g/m2) and G-CSF in order to collect peripheral blood progenitor cells (PBPC). Fourteen patients were in partial remission, 16 patients

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::e30a61cf0f2c9f0dfd2a1bcbd628d720
https://pubmed.ncbi.nlm.nih.gov/8649061

Zobrazit plný text záznamu

Recombinant human erythropoietin in the anemia associated with multiple myeloma or non-Hodgkin's lymphoma: dose finding and identification of predictors of response

Autor: M, Cazzola, D, Messinger, V, Battistel, D, Bron, R, Cimino, L, Enller-Ziegler, U, Essers, R, Greil, A, Grossi, G, Jäger, A, LeMevel, A, Najman, V, Silingardi, M, Spriano, A, van Hoof, B, Ehmer

Publikováno v: Blood. 86(12)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::b3304cbf1f66d325bd6fac32074a2b3b
https://pubmed.ncbi.nlm.nih.gov/8541533

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání